Insmed, Inc. (INSM)
159.80
-0.59
(-0.37%)
USD |
NASDAQ |
Jan 23, 09:45
Insmed Cash from Investing (Quarterly): -762.23M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 501.11M |
| Biogen, Inc. | -35.10M |
| CorMedix, Inc. | -291.32M |
| Merck & Co., Inc. | -283.00M |
| Pfizer Inc. | -2.43B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -219.76M |
| Cash from Financing (Quarterly) | 33.41M |
| Free Cash Flow | -906.14M |
| Free Cash Flow Per Share (Quarterly) | -1.049 |
| Free Cash Flow to Equity (Quarterly) | -223.92M |
| Free Cash Flow to Firm (Quarterly) | -201.72M |
| Free Cash Flow Yield | -2.98% |